Company: Bristol-Myers Squibb Company
Ticker: BMY
Form: 10-K
Filed: 2026-02-11
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Bristol-Myers Squibb Company's total assets in fiscal year 2025?
Question Type: value_lookup

Concept: Assets
Answer (Numeric): 90038.0
Answer (Display): $90,038 million
Unit: USD millions

Evidence:
[{"chunk_id": "199", "equivalent_chunk_ids": ["199"], "section": "CONSOLIDATED BALANCE SHEETS", "supports": ["main"], "text": "Dollars in millions, except share and per share data\nDecember 31,\nASSETS\nCurrent assets:\nCash and cash equivalents\n10,209\n10,346\nMarketable debt securities\nReceivables\n11,414\n10,747\nInventories\n2,690\n2,557\nOther current assets\n4,613\n5,617\nTotal Current assets\n29,390\n29,780\nProperty, plant and equipment\n7,543\n7,136\nGoodwill\n21,754\n21,719\nOther intangible assets\n19,103\n23,307\nDeferred income taxes\n5,378\n4,236\nMarketable debt securities\nOther non-current assets\n6,474\n6,105\nTotal Assets\n90,038\n92,603\nLIABILITIES\nCurrent liabilities:\nShort-term debt obligations\n2,261\n2,046\nAccounts payable\n3,575\n3,602\nOther current liabilities\n17,581\n18,126\nTotal Current liabilities\n23,417\n23,774\nDeferred income taxes\nLong-term debt\n42,850\n47,603\nOther non-current liabilities\n5,043\n4,469\nTotal Liabilities\n71,533\n76,215\nCommitments and Contingencies (Note 20)\nEQUITY\nBristol-Myers Squibb Company Shareholders’ Equity:\nPreferred stock, $\nconvertible series, par value $\nper share: Authorized\nmillion shares; issued and outstanding\n2,510\nin 2025 and\n2,868\nin 2024, liquidation value of $\nper share\nCommon stock, par value of $\n0.10\nper share: Authorized\nbillion shares;\nbillion issued in 2025 and 2024\nCapital in excess of par value of stock\n46,387\n46,024\nAccumulated other comprehensive loss\n1,524\n1,238\nRetained earnings\n16,896\n14,912\nLess cost of treasury stock —\nmillion common shares in 2025 and\nmillion common shares in 2024\n43,579\n43,655\nTotal BMS Shareholders’ Equity\n18,473\n16,335\nNoncontrolling interest\nTotal Equity\n18,506\n16,388\nTotal Liabilities and Equity\n90,038\n92,603\nThe accompanying notes are an integral part of these consolidated financial statements.\nBRISTOL-MYERS SQUIBB COMPANY"}]

Derivation: